. Total revenue from sale of goods in the number of 2,382.38 million Baht was increased by 23.74 million Baht or 1.01% from Q1 of the previous fiscal year. The sale growth rates compared to the Q1 of the
number of 2,429.97 million Baht was increased by 15.58 million Baht or 0.65% from Q2 of the previous fiscal year. The sale growth rates compared to the Q2 of the previous fiscal year are from our 3
goods in the number of 2,371.16 million Baht was increased by 68.34 million Baht or 2.97% from Q3 of the previous fiscal year. The sale growth rates compared to the Q3 of the previous fiscal year are from
2018), all due to the significant changes as follows: 1. Total revenue from sale of goods in the number of 2,427.7 million Baht decreased by 312.8 million Baht or 11.4% from the previous fiscal year. The
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 No. DOD089/2563
Company Limited (the “Company”) would like to submit the financial statements for the fiscal year ended December 31 st , 2019, which have been audited by the independent auditor. The Company’s net profit
The Securities and Exchange Commission (SEC), represented by the Capital Market Education Department, in collaboration with the Fiscal Policy Office (FPO), the Deposit Protection Agency (DPA), and